Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Several new treatment options have become available for pancreatic ductal adenocarcinoma (PDAC), but the support for their use for resectable, borderline resectable and locally advanced PDAC is unclear. | Opinions and use of neoadjuvant therapy for resectable borderline resectable and locally advanced pancreatic cancer International survey and case-vignette study